CID 5275928

Schembl9780533

Structural Information

Molecular Formula
C18H21N3O5
SMILES
CCC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CNC(=O)C3=CC=CC=C3)O
InChI
InChI=1S/C18H21N3O5/c1-2-11-10-21(18(25)20-17(11)24)15-8-13(22)14(26-15)9-19-16(23)12-6-4-3-5-7-12/h3-7,10,13-15,22H,2,8-9H2,1H3,(H,19,23)(H,20,24,25)/t13-,14+,15+/m0/s1
InChIKey
YBIPXNGIZQPUCU-RRFJBIMHSA-N
Compound name
N-[[(2R,3S,5R)-5-(5-ethyl-2,4-dioxopyrimidin-1-yl)-3-hydroxyoxolan-2-yl]methyl]benzamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

7
Patents

359.14813 Da
Monoisotopic Mass

0.9
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 360.15541 183.2
[M+Na]+ 382.13735 189.8
[M-H]- 358.14085 189.0
[M+NH4]+ 377.18195 191.7
[M+K]+ 398.11129 185.8
[M+H-H2O]+ 342.14539 173.8
[M+HCOO]- 404.14633 200.3
[M+CH3COO]- 418.16198 211.5
[M+Na-2H]- 380.12280 182.6
[M]+ 359.14758 182.6
[M]- 359.14868 182.6
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe